AP Anthony Bosch

Who is Anthony Bosch?

40 Comments

In the wake of ESPN’s Tuesday night report about Major League Baseball’s investigation and potential suspension of as many as two dozen players linked to the Biogenesis clinic in Miami, the spotlight has shone on one man more than any other: Anthony Bosch, the owner of the Biogenesis of America clinic and now the man who is reportedly prepared to turn over everything he knows about his famous clients to Major League Baseball.

But who is Anthony Bosch? What do we know about him?

Not much. We know he was born in Miami and grew up in comfortable circumstances. His father, Pedro Bosch, has been a successful physician for nearly 40 years. He has had multiple marriages and multiple failed businesses, with Biogenesis being the last.

Biogenesis was an “anti-aging” clinic that, superficially anyway, was like many in Florida. It was just across U.S. 1 from the University of Miami, housed in what was once a motel. Like other anti-aging clinics, it was a quasi-medical establishment which offered its mostly wealthy clients assistance in weight loss, physical fitness, and in some cases psychological services. Better living through therapy and chemistry. Such clinics are not licensed or regulated by the State of Florida.

The “quasi” part of that comes from the fact that Bosch is not a physician. His only known degree was obtained in 2009 from the Central America Health Sciences University in Belize, which he claimed to be a medical degree and displayed it on his office wall. According to the Miami New Times he wore a lab coat with “Dr. Tony Bosch” on it and gave the impression to many that he was, in fact, a doctor.

He did something else only doctors are allowed to do: as the New York Times reported in February, Bosch would obtain prescription drugs for his patients, including human growth hormone. His methods of doing so is unknown and are subject to an investigation by the Florida Department of Health and referrals to the Miami State Attorney’s office and the Florida Attorney General’s office. The New York Times report on Biogenesis in February described Bosch’s clinic as disheveled and disorganized. A former business partner of Bosch’s was surprised that Bosch was alleged to have worked with high-profile athletes, saying “I don’t know how the guy can tie his shoes, let alone have A-Rod as a client.”

But his business records, obtained by the Miami New Times suggest that he did indeed supply performance enhancing drugs to many ballplayers, A-Rod included. Most of the drug distributions were reported to have been made through intermediaries rather than to the ballplayers themselves. One of the alleged intermediaries was an employee of player agents the Levinson brothers. In the case of Alex Rodriguez, however, Bosch is alleged to have actually injected the player personally, doing so at Rodriguez’s home. All involved have denied the allegations.

Bosch himself denied any allegation that he supplied performance enhancing drugs to players, telling ESPN in April that such allegations are lies:

“I have been accused, tried and convicted in the media. And so I think have been falsely accused throughout the media … I am a nutritionist. I don’t know anything about performance-enhancing drugs.”

But that has all changed now. Major League Baseball sued Bosch in March, alleging that he tortiously interfered with baseball’s Joint Drug Agreement, damaging the game. On Thursday morning it was reported that, some time after that suit was filed, Bosch approached Alex Rodriguez in an effort to obtain his financial assistance in the face of the lawsuit and other investigations into his activities. Rodriguez is reported to have denied any assistance to Bosch.

Now, Bosch and Major League Baseball are reported to have come to an agreement in which the lawsuit will be dismissed against him, he will provide testimony and documents to Major League Baseball in furtherance of its investigation into Biogenesis-connected ballplayers and will indemnify him for any legal repercussions occasioned by his cooperation. While the baseball officials have not yet spoken to Bosch, it is reasonable to assume that the league’s cooperation with Bosch is based on him providing information which would implicate ballplayers in the use of performance enhancing drugs.

Who Should win the Rookie of the Year Awards? Who Will?

LOS ANGELES, CA - SEPTEMBER 05:  Corey Seager #5 of the Los Angeles Dodgers reacts to his three run homerun for a 6-0 lead over the Arizona Diamondbacks during the fifth inning at Dodger Stadium on September 5, 2016 in Los Angeles, California.  (Photo by Harry How/Getty Images)
Getty Images
1 Comment

With the regular season ending on Sunday and most of the playoff spots locked up, there’s really only one big thing left to argue about: postseason awards. So let’s spend some time looking at who should win each of the four major awards and who will win them. Which are often totally different things. Next up: The Rookie of the Year Awards

This is a whole heck of a lot easier than the MVP and Cy Young Awards, that’s for sure. It’s a two horse race in the AL and a one-horse race in the NL.

Who should win the AL Rookie of the Year Award?

It seemed like Tigers starter Michael Fulmer would be the no-brainer choice for a good long while, as his low ERA and solid performance helped carry the Tigers when their starting pitching wasn’t doing them any favors. But then the Yankees called up catcher Gary Sanchez at the beginning of August and all he’s done since then is hit .303/.378/.672 with an astonishing 20 homers in his first 51 games. Fulmer has continued to be solid — he’s just short of qualifying for the ERA title, but does have the league’s lowest ERA at 3.06 — but Sanchez has been spectacular.

The MVP and Cy Young Award require full season contributions. Not everyone takes the Rookie of the Year Award quite as seriously, it seems, and are thus more willing to entertain smaller samples of excellence over large samples of solid work when it comes to the award. That’s how Bill and I think about it anyway, giving the nod to Sanchez’s historic two-month run. Ashley, however, favors Fulmer’s larger volume of work. You can’t really go wrong with either choice:

Craig: Sanchez
Bill: Sanchez
Ashley: Fulmer

Who will win the AL Rookie of the Year Award?

Hard call. I have no idea what voters will do on that quantity/quality calculation. I’ll guess Fulmer, but it’s just a guess. I could just as easily see Sanchez given some quasi-MVP credit for helping the Yankees remain relevant after the trade deadline and throw it his way.

 

Who should win the NL Rookie of the Year Award?

If you say anyone other than Corey Seager, and his .311/.369/.519 26 homer batting line, the state has authorized me to have you taken to a hospital for 48 hours of examination, at which point your competence to reenter society will be gauged. But there is ice cream there.

Craig: Seager
Bill: Seager
Ashley: Seager

 

Who will win the NL Rookie of the Year Award?

If any BBWAA voter lists anyone other than Corey Seager at the top of his or her Rookie of the Year ballot, the state has authorized me to have them taken to a hospital for 48 hours of examination, at which point their competence to reenter society will be gauged. They will not, however, be allowed to have any ice cream because, really, they should know better. They’re professionals.

Jeremy Giambi vs. David Ortiz

jeremy-giambi
4 Comments

The 2002 Red Sox won 93 games, only to finish 10 games behind the Yankees in the AL West and six back of the lone wild card. They named Theo Epstein the GM that November and allowed him to begin reshaping the team, then led by Pedro Martinez and Manny Ramirez.

The Red Sox didn’t make any big splashes that winter. Their biggest free agent signing was Ramiro Mendoza, who got $6.5 million for two years. They also signed Mike Timlin and Bill Mueller (who played behind Shea Hillenbrand at third initially). They traded for Todd Walker. They stole Bronson Arroyo off waivers.

What Epstein did totally overhaul was a first base-DH situation that held the team back the previous season. 2002 trade deadline pickup Cliff Floyd exited in free agency, as did disappointments Tony Clark and Jose Offerman.

Brought in was a three-headed monster of underappreciated, high-OBP, Moneyball-type players. First, the Red Sox traded Josh Hancock to the Phillies for Jeremy Giambi, who had just hit .244/.435/.538 in 156 at-bats after coming over from the A’s at midseason. He hit .272/.402/.475 in 684 at-bats total between 2001 and 2002, and he looked like he was still very much in his prime at age 28.

The day after the Giambi trade, the Twins made the move to release David Ortiz. No one pounced, though, and Ortiz remained unsigned for a month before joining the Boston on a one-year, $1.25 million contract. Ortiz, who was entering his age-27 season, hit .272/.339/.500 in 412 at-bats for the Twins in 2002.

While that was going on, the Red Sox were working to bring in Kevin Millar for first base. Millar hit .306/.366/.509 in 438 at-bats for the Marlins in 2002 and was even better the previous season, but he was a poor outfielder and third baseman and the team already had Derrek Lee at first base. So, the Marlins, rather than trade Millar for a player, sold him to Japan for some much-preferred cash. Millar, not realizing that he was a desired commodity around the league, went along with the plan. That’s when the Red Sox broke an unwritten rule and claimed Millar off waivers. It turned into a long ordeal, but the Red Sox were finally able to land Millar in February by buying him from the Marlins.

I remember at the time being most excited about the Giambi acquisition. He couldn’t play defense and he had gotten himself exiled by the A’s for some transgression the previous year, but he looked like an awesome offensive force with his terrific power and ridiculous walk rate. Ortiz was certainly worth taking the chance on, too, but I thought Giambi would be better and leave Ortiz with little to do.

Indeed, Giambi started over Ortiz on Opening Day. However, both got off to lousy starts and Giambi’s playing time quickly diminished. Giambi finished April at .125/.288/.292 in 60 plate appearances, starting only once in the final week of the month. Ortiz came in at .212/.311/.346 in 61 plate appearances.

Both players found their strokes at the beginning of May. For Giambi, though, it amounted to all of about two weeks of success. He peaked with an .828 OPS on May 16. Ortiz’s build was slower, but it lasted. He had a .942 OPS in May, a .961 OPS in June, a .987 OPS in July and a 1.097 OPS in August before plummeting all of the way to .977 in September. He finished 5th in the AL MVP balloting despite playing about half the time the first two months.

Giambi, finding himself more starved for at-bats after Ortiz heated up, landed on the DL in late June with a bad shoulder. At the time, it looked like it might have been a made-up injury to get him playing time in the minors for a spell. It wasn’t. He returned a few weeks later, but he still wasn’t right. He made his last appearance on Aug. 1, going 0-for-3 against the Orioles. He landed back on the DL and then underwent surgery to repair damage in his labrum and rotator cuff.

As it turned out, Giambi never played in the majors again. As he was trying to come back from the shoulder surgery the next spring, he developed back problems. He played in 17 minor league games with the Dodgers in 2004 and nine with the White Sox in 2005. That was it for him, and he was done at 30 years old. In early 2005, he admitted to using BALCO-provided steroids and said that he regretted it. The strength training likely played roles in both his emergence and his downfall, given the breakdown of his body.

Things worked out a little differently for Ortiz…

Ortiz through 2002 (age 26): .266/.348/.461, 108 OPS+ in 1,693 PA
Giambi through 2002 (age 27): .269/.381/.437, 114 OPS+ in 1,549 PA

Ortiz after 2002: .290/.386/.570, 148 OPS+ in 8,387 PA
Giambi after 2002: .197/.342/.354, 81 OPS+ in 156 PA

And those 2003 Red Sox? Well, they won 95 games, which was good enough for the wild card this time. Still, they lost to the Yankees in seven games in the ALCS. They were still one year away.